DM

Disc Medicine, Inc.

IRON·NASDAQ

$70.35

-2.3%
HealthcareBiotechnology

Disc Medicine, Inc., a clinical-stage biotechnology company, engages in discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases. It builds a portfolio of therapeutic candidates that address a spectrum of hematologic diseases by targeting fundamental biological pathways of red blood cell biology, primarily heme biosynthesis and iron homeostasis. The company is based in Watertown, Massachusetts.

At a Glance

Live Snapshot
Market Cap$2.69B
EPS-6.0100
P/E Ratio-11.71
Earnings Date08/06/2026

iron

Prepaids

Last Annual Value

0.00

3-Year CAGR

%

5-Year CAGR

%

10-Year CAGR

%

DM

Disc Medicine, Inc. Competitors Analysis of Prepaids

IRON · NASDAQ
CompanyPrepaids
CAGR 3Y
CAGR 5Y
CAGR 10Y
0.00
N/AN/AN/A 
13.47M
19.6%27.2%N/A
CELC logo
Celcuity Inc.
NASDAQ:CELC
0.00
N/AN/AN/A
0.00
N/AN/AN/A
0.00
N/AN/AN/A
0.00
N/AN/AN/A
14.60M
6.1%20.6%N/A
0.00
N/AN/AN/A
DM

Disc Medicine, Inc. Fair Value Envelope

IRON · NASDAQ

Our analysis suggests that IRON has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $70.35, this represents a potential HIDDEN relative to our calculated worth for Disc Medicine, Inc..

Intrinsic Value
Current Price: $70.35